Status:

COMPLETED

Ranitidin Versus Omeprazole in Patients Taking Clopidogrel

Lead Sponsor:

University of Sao Paulo General Hospital

Collaborating Sponsors:

InCor Heart Institute

Conditions:

Coronary Artery Disease

Drug Interaction Potentiation

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Previous reports have shown a possible drug interaction between clopidogrel and proton pump inhibitors (PPI´s), which could result in increased number of adverse cardiovascular events among patients o...

Detailed Description

Study population: 100 patients with Stable Coronary Artery Disease from Heart Institute Inclusion Criteria: * Age \> 18 years old * Coronary artery disease, defined as previous myocardial infarction...

Eligibility Criteria

Inclusion

  • Age \> 18 years old
  • Coronary artery disease, defined as previous myocardial infarction and/or coronary angioplasty and/or CABG surgery and/or coronariography showing obstruction of at least 50 % in one of major epicardial vessels
  • Treatment with Acetylsalicylic Acid (ASA) 100 mg/day

Exclusion

  • Use on the last 7 days of any other antiplatelet drug beside ASA or oral anticoagulant
  • Previous utilization of PPI or ranitidine in the last 7 days before randomization
  • Any active bleeding
  • Pregnancy or woman of childbearing age without contraceptive method
  • Hemoglobin \< 10 g/dL or hematocrit \< 30 %, hematocrit \> 50 %, platelets \< 100.000/mm3 or \> 500.000/mm3; creatinin clearance \< 50 ml/minute
  • Percutaneous coronary intervention (PCI) on the last 30 days before randomization (or PCI on the last year when drug-eluted stents are used); CABG surgery on the last 90 days; acute coronary syndrome on the last 60 days
  • Active malignant neoplasm
  • Active peptic ulcer disease on the last 60 days or upper gastrointestinal bleeding any time in life
  • Known allergy to the drugs clopidogrel, ranitidine or omeprazole
  • Refuse to participate in the study

Key Trial Info

Start Date :

October 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2013

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT01896557

Start Date

October 1 2011

End Date

June 1 2013

Last Update

July 6 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.